A new Stifel research report includes the firm's biotech stock picks for 2021. These five have the biggest upside to the posted price targets and are best suited for patient, aggressive growth...
Health care has been a top performer this year, and there is every reason to believe that performance will carry through into 2021. These are four of the highest-ranked health care ideas from the...
Tuesday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Beyond Meat, CommScope, Enphase Energy, Nabors Industries, Netflix, Nike, Roku, Tesla, Uber Technologies and...
Here are eight secondary offerings that have been filed with a grand tally of about $3 billion combined.
Spark Therapeutics shares more than doubled in Tuesday’s session as the result of its pending acquisition. However, the root of the buyout was its gene therapy, which could drive more acquisitions...
The top analyst upgrades, downgrades and other research calls from Tuesday include AK Steel, BHP Billiton, Dominion Energy, JB Hunt, KLA-Tencor, Micron Technology, Nucor, Oracle, Roku and U.S. Steel.
The top analyst upgrades, downgrades and other research calls from Friday include AT&T, E*Trade, PG&E, Plug Power, Priceline, Tiffany and VMware.
24/7 Wall St. has collected several catalysts that are coming up on the calendar in the month of July and added some color.
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Cliffs Natural Resources, Deere, Lockheed Martin, Micron Technology and Zillow.
If the momentum in biotech can continue, then companies with catalysts within the next 12 to 18 months could get an added boost with any good news.
Friday's top analyst calls include Best Buy, 3D Systems, Electronic Arts, Gilead Sciences, Nokia, Shire and United Rentals.
If you just looked at a 369-point gain on the Dow on Friday, you might think it was a great week. That gain merely wiped out two days of big losses and the Dow closed up about 0.2% on the week. The...
Tuesday's top analyst upgrades, downgrades and initiations include AbbVie, CDW, CSC, Eli Lilly, Ericsson, Gold Fields, JD.com, Nokia and Rackspace.
New drug innovations are affecting the way that physicians treat such debilitating and deadly diseases as cancer. In a new research report, Jefferies presents the top drug innovations that investors...